Global Antidepressants Market Report 2025

Antidepressants Global Market Report 2025 – By Product (Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhibitor (MAOI)), By Drug Class (Monoamine Oxidase Inhibitors, Serotonin Antagonist And Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants), By Depressive Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder) – Market Size, Trends, And Global Forecast 2025-2034

Antidepressants Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Antidepressants Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Antidepressants Market Definition

Antidepressants refer to a medication that aids in the treatment of depressive symptoms. Additionally, they can aid in the treatment of SAD, other anxiety disorders, and social anxiety disorder. Unpleasant side effects are possible with antidepressants. Initially, signs and symptoms including nausea, weight gain, or sleep issues can be prevalent.

The main product types of antidepressants are selective serotonin reuptake inhibitor (SSRI), serotonin-norepinephrine reuptake inhibitor (SNRI), tricyclic antidepressant (TCA), and monoamine oxidase inhibitor (MAOI). SSRIs (selective serotonin reuptake inhibitors) are a type of medication that is commonly used to treat depression and a few other mental illnesses. The various drug class includes monoamine oxidase inhibitors, serotonin antagonist and reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, selective serotonin reuptake inhibitors, and tricyclic antidepressants that are used for the treatment of the major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, and panic disorder.

Antidepressants Market Segmentation

The antidepressants market covered in this report is segmented –

1) By Product: Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhibitor (MAOI)

2) By Drug Class: Monoamine Oxidase Inhibitors, Serotonin Antagonist And Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants

3) By Depressive Disorder: Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder

Subsegments:

1) By Selective Serotonin Reuptake Inhibitor (SSRI): Fluoxetine, Sertraline, Escitalopram, Paroxetine, Citalopram

2) By Serotonin-norepinephrine Reuptake Inhibitor (SNRI): Venlafaxine, Duloxetine, Desvenlafaxine

3) By Tricyclic Antidepressant (TCA): Amitriptyline, Nortriptyline, Imipramine, Doxepin

4) By Monoamine Oxidase Inhibitor (MAOI): Phenelzine, Tranylcypromine, Isocarboxazid

Antidepressants Market Size and growth rate 2025 to 2029: Graph

Antidepressants Market Size 2025 And Growth Rate

The antidepressants market size has grown steadily in recent years. It will grow from $17.11 billion in 2024 to $17.82 billion in 2025 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to increasing prevalence of mental health disorders, growing awareness and reduced stigma, advancements in diagnostic practices, expansion of treatment options, government initiatives and mental health policies.

Antidepressants Market Growth Forecast

The antidepressants market size is expected to see steady growth in the next few years. It will grow to $20.25 billion in 2029 at a compound annual growth rate (CAGR) of 3.2%. The growth in the forecast period can be attributed to rising mental health awareness and advocacy, global impact of stress and lifestyle changes, integration of mental health services, research and development in psychiatry, telemedicine and remote mental health services. Major trends in the forecast period include regulatory changes, market competition, generic market growth, focus on side effect profiles, emerging markets.

Antidepressants Market Driver: Surge In Mental Health Disorders Fuels Antidepressant Drug Industry Growth

Globally, rising cases of mental health disorders are the key factor in the growth of the antidepressant drug industry, as many customers rely on these medications to counter depression, anxiety disorder, and other mental diseases. Antidepressant medications are used in conditions such as depression, OCD, childhood enuresis, major depressive disorder, severe anxiety disorder, bipolar disorder, post-traumatic stress disorder (PTSD), and social anxiety disorder. Globally, the percentage of people with depression varies from 2% to 6%, and the elderly are at greater risk of depression compared to other age groups. According to WHO, in 2023, about 280 million people globally suffered from depression. Therefore, rising cases of mental health disorders are expected to drive the growth of the antidepressant market.

Antidepressants Market Driver: Rising Cases Of Mental Illness

The increasing mental illness is expected to propel the demand for the antidepressants market going forward. A mental illness is a disorder that impacts the way a person thinks, feels, behaves, or believes. These illnesses occur due to distress or difficulties functioning in social, job, or family activities. Antidepressants are a type of medication used to treat various mental health conditions, including depression, anxiety, and mood disorders. It works by increasing the levels of certain chemicals in the brain that are responsible for regulating mood and emotions. For instance, in November 2022, according to the National Health Service, an England-based government department, in individuals aged 17 to 19, the prevalence of probable mental disorders increased from 1 in 6 (17.4%) in 2021 to 1 in 4 (25.7%) in 2022. Therefore, increasing mental illness will drive the antidepressants market.

Global Antidepressants Market Major Players

Major companies operating in the antidepressants market include Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol Myers Squibb Company, Fresenius Kabi AG, Abbott Laboratories, AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd., Eli Lilly and Company, Boehringer Ingelheim GmbH, H. Lundbeck AS, Teva Pharmaceutical Industries Ltd., Akeda Pharmaceutical Co., Otsuka Pharmaceutical Co., Mylan N.V, Sun Pharmaceuticals Pvt. Ltd., Servier Laboratories, Sumitomo Dainippon Pharma Co., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Allergan plc, Alkermes plc, Egis Pharmaceuticals plc, Forest Laboratories Inc.

Global Antidepressants Market Trend: Ketamine Treatment Reshaping The Antidepressant Market

The treatment of resistant depression is a key trend in the antidepressant market. Ketamine is the new treatment that is used for anesthesia during surgery, stimulates the development of glutamate, and prompts the brain to form new neural connections. It makes the brain more adaptable and capable of developing new pathways and helps people to create more optimistic thoughts and behaviors. For instance, Food and Drug Administration (FDA) approved a new ketamine depression drug esketamine which is one-half of the ketamine compound. The drug must be administered as a nasal spray and patients must be taking another antidepressant at the same time. Also, the drugs can be prescribed to only those patients who have (unsuccessfully) tried two antidepressants before.

Global Antidepressants Market Trend: Novel Treatment Introduction In The Antidepressant Market

Major companies operating in the antidepressant market are increasing their focus on introducing new drugs such as the ZURZUVAE (zuranolone) for treatment of postpartum depression (PPD) to maximize revenue in the market. Postpartum depression (PPD) is a type of depression that can occur after giving birth. It is a serious mental health condition that can affect both new mothers and fathers. For instance, in August 2023, Biogen Inc a US-based biotechnology company and Sage Therapeutics, Inc. US-based a biopharmaceutical company launched ZURZUVAE (zuranolone), a 50 mg oral treatment for postpartum depression (PPD) in women. This marks a significant advancement, addressing the underdiagnosed and undertreated condition of PPD. ZURZUVAE (zuranolone) is an oral treatment primarily used for postpartum depression (PPD) and is the first and only FDA-approved medication designed specifically for this condition.

Antidepressants Market Merger And Acquisition: Abbvie Acquires Cerevel Therapeutics To Enhance Neurological Treatment Portfolio

In December 2023, AbbVie Inc., a US-based pharmaceutical company, acquired Cerevel Therapeutics Holdings, Inc. for $8.7 billion. This strategic acquisition aims to strengthen AbbVie's capabilities in addressing complex neurological conditions and enhancing patient outcomes through improved therapeutic options. Cerevel Therapeutics Holdings, Inc. is a US-based clinical-stage biopharmaceutical company, that specializes in developing innovative therapies for disorders of the central nervous system (CNS).

Regional Outlook For The Global Antidepressants Market

North America was the largest region in the antidepressants market in 2024. Middle East is expected to be the largest growing region in the global antidepressants market during the forecast period. The regions covered in the antidepressants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the antidepressants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Antidepressants Market?

The antidepressants market consists of sales of duloxetine, desvenlafaxine, vilazodone, citalopram, and sertraline. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Antidepressants Industry?

The antidepressants market research report is one of a series of new reports from The Business Research Company that provides antidepressants market statistics, including antidepressants industry global market size, regional shares, competitors with an antidepressants market share, detailed antidepressants market segments, market trends, and opportunities, and any further data you may need to thrive in the antidepressants industry. This antidepressants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Antidepressants Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $17.82 billion
Revenue Forecast In 2034 $20.25 billion
Growth Rate CAGR of 3.2% from 2024 to 2033
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product: Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhibitor (MAOI)
2) By Drug Class: Monoamine Oxidase Inhibitors, Serotonin Antagonist And Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants
3) By Depressive Disorder: Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder Subsegments: 1) By Selective Serotonin Reuptake Inhibitor (SSRI): Fluoxetine, Sertraline, Escitalopram, Paroxetine, Citalopram
2) By Serotonin-norepinephrine Reuptake Inhibitor (SNRI): Venlafaxine, Duloxetine, Desvenlafaxine
3) By Tricyclic Antidepressant (TCA): Amitriptyline, Nortriptyline, Imipramine, Doxepin
4) By Monoamine Oxidase Inhibitor (MAOI): Phenelzine, Tranylcypromine, Isocarboxazid
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol Myers Squibb Company, Fresenius Kabi AG, Abbott Laboratories, AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd., Eli Lilly and Company, Boehringer Ingelheim GmbH, H. Lundbeck AS, Teva Pharmaceutical Industries Ltd., Akeda Pharmaceutical Co., Otsuka Pharmaceutical Co., Mylan N.V, Sun Pharmaceuticals Pvt. Ltd., Servier Laboratories, Sumitomo Dainippon Pharma Co., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Allergan plc, Alkermes plc, Egis Pharmaceuticals plc, Forest Laboratories Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Antidepressants Market Characteristics

    3. Antidepressants Market Trends And Strategies

    4. Antidepressants Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

    5. Global Antidepressants Growth Analysis And Strategic Analysis Framework

    5.1. Global Antidepressants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Antidepressants Market Growth Rate Analysis

    5.4. Global Antidepressants Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Antidepressants Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Antidepressants Total Addressable Market (TAM)

    6. Antidepressants Market Segmentation

    6.1. Global Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Selective Serotonin Reuptake Inhibitor (SSRI)

    Serotonin-norepinephrine Reuptake Inhibitor (SNRI)

    Tricyclic Antidepressant (TCA)

    Monoamine Oxidase Inhibitor (MAOI)

    6.2. Global Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Monoamine Oxidase Inhibitors

    Serotonin Antagonist And Reuptake Inhibitors

    Serotonin-Norepinephrine Reuptake Inhibitors

    Selective Serotonin Reuptake Inhibitors

    Tricyclic Antidepressants

    6.3. Global Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Major Depressive Disorder

    Obsessive-Compulsive Disorder

    Generalized Anxiety Disorder

    Panic Disorder

    6.4. Global Antidepressants Market, Sub-Segmentation Of Selective Serotonin Reuptake Inhibitor (SSRI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Fluoxetine

    Sertraline

    Escitalopram

    Paroxetine

    Citalopram

    6.5. Global Antidepressants Market, Sub-Segmentation Of Serotonin-norepinephrine Reuptake Inhibitor (SNRI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Venlafaxine

    Duloxetine

    Desvenlafaxine

    6.6. Global Antidepressants Market, Sub-Segmentation Of Tricyclic Antidepressant (TCA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Amitriptyline

    Nortriptyline

    Imipramine

    Doxepin

    6.7. Global Antidepressants Market, Sub-Segmentation Of Monoamine Oxidase Inhibitor (MAOI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Phenelzine

    Tranylcypromine

    Isocarboxazid

    7. Antidepressants Market Regional And Country Analysis

    7.1. Global Antidepressants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Antidepressants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Antidepressants Market

    8.1. Asia-Pacific Antidepressants Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Antidepressants Market

    9.1. China Antidepressants Market Overview

    9.2. China Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Antidepressants Market

    10.1. India Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Antidepressants Market

    11.1. Japan Antidepressants Market Overview

    11.2. Japan Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Antidepressants Market

    12.1. Australia Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Antidepressants Market

    13.1. Indonesia Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Antidepressants Market

    14.1. South Korea Antidepressants Market Overview

    14.2. South Korea Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Antidepressants Market

    15.1. Western Europe Antidepressants Market Overview

    15.2. Western Europe Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Antidepressants Market

    16.1. UK Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Antidepressants Market

    17.1. Germany Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Antidepressants Market

    18.1. France Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Antidepressants Market

    19.1. Italy Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Antidepressants Market

    20.1. Spain Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Antidepressants Market

    21.1. Eastern Europe Antidepressants Market Overview

    21.2. Eastern Europe Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Antidepressants Market

    22.1. Russia Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Antidepressants Market

    23.1. North America Antidepressants Market Overview

    23.2. North America Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Antidepressants Market

    24.1. USA Antidepressants Market Overview

    24.2. USA Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Antidepressants Market

    25.1. Canada Antidepressants Market Overview

    25.2. Canada Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Antidepressants Market

    26.1. South America Antidepressants Market Overview

    26.2. South America Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Antidepressants Market

    27.1. Brazil Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Antidepressants Market

    28.1. Middle East Antidepressants Market Overview

    28.2. Middle East Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Antidepressants Market

    29.1. Africa Antidepressants Market Overview

    29.2. Africa Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Antidepressants Market Competitive Landscape And Company Profiles

    30.1. Antidepressants Market Competitive Landscape

    30.2. Antidepressants Market Company Profiles

    30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

    31. Antidepressants Market Other Major And Innovative Companies

    31.1. Novartis AG

    31.2. Sanofi S.A.

    31.3. Bristol Myers Squibb Company

    31.4. Fresenius Kabi AG

    31.5. Abbott Laboratories

    31.6. AstraZeneca plc

    31.7. GlaxoSmithKline plc

    31.8. Takeda Pharmaceutical Co. Ltd.

    31.9. Eli Lilly and Company

    31.10. Boehringer Ingelheim GmbH

    31.11. H. Lundbeck AS

    31.12. Teva Pharmaceutical Industries Ltd.

    31.13. Akeda Pharmaceutical Co.

    31.14. Otsuka Pharmaceutical Co.

    31.15. Mylan N.V

    32. Global Antidepressants Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Antidepressants Market

    34. Recent Developments In The Antidepressants Market

    35. Antidepressants Market High Potential Countries, Segments and Strategies

    35.1 Antidepressants Market In 2029 - Countries Offering Most New Opportunities

    35.2 Antidepressants Market In 2029 - Segments Offering Most New Opportunities

    35.3 Antidepressants Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Antidepressants Market, Sub-Segmentation Of Selective Serotonin Reuptake Inhibitor (SSRI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Antidepressants Market, Sub-Segmentation Of Serotonin-norepinephrine Reuptake Inhibitor (SNRI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Antidepressants Market, Sub-Segmentation Of Tricyclic Antidepressant (TCA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Antidepressants Market, Sub-Segmentation Of Monoamine Oxidase Inhibitor (MAOI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Antidepressants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Antidepressants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Pfizer Inc. Financial Performance
  • Table 79: Johnson & Johnson Services Inc. Financial Performance
  • Table 80: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 81: Merck & Co. Inc. Financial Performance
  • Table 82: AbbVie Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Antidepressants Market, Sub-Segmentation Of Selective Serotonin Reuptake Inhibitor (SSRI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Antidepressants Market, Sub-Segmentation Of Serotonin-norepinephrine Reuptake Inhibitor (SNRI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Antidepressants Market, Sub-Segmentation Of Tricyclic Antidepressant (TCA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Antidepressants Market, Sub-Segmentation Of Monoamine Oxidase Inhibitor (MAOI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Antidepressants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Antidepressants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Antidepressants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Antidepressants Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Antidepressants Market, Segmentation By Depressive Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Pfizer Inc. Financial Performance
  • Figure 79: Johnson & Johnson Services Inc. Financial Performance
  • Figure 80: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 81: Merck & Co. Inc. Financial Performance
  • Figure 82: AbbVie Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Antidepressants market?

Antidepressants refer to a medication that aids in the treatment of depressive symptoms. Additionally, they can aid in the treatment of SAD, other anxiety disorders, and social anxiety disorder. Unpleasant side effects are possible with antidepressants. Initially, signs and symptoms including nausea, weight gain, or sleep issues can be prevalent. For further insights on the Antidepressants market, request a sample here

How will the Antidepressants market drivers and restraints affect the market dynamics? What forces will shape the Antidepressants industry going forward?

The Antidepressants market major growth driver - Surge In Mental Health Disorders Fuels Antidepressant Drug Industry Growth. For further insights on the Antidepressants market, request a sample here

What is the forecast market size or the forecast market value of the Antidepressants market?

The Antidepressants market size has grown strongly in recent years. The antidepressants market size has grown steadily in recent years. It will grow from $17.11 billion in 2024 to $17.82 billion in 2025 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to increasing prevalence of mental health disorders, growing awareness and reduced stigma, advancements in diagnostic practices, expansion of treatment options, government initiatives and mental health policies. The antidepressants market size is expected to see steady growth in the next few years. It will grow to $20.25 billion in 2029 at a compound annual growth rate (CAGR) of 3.2%. The growth in the forecast period can be attributed to rising mental health awareness and advocacy, global impact of stress and lifestyle changes, integration of mental health services, research and development in psychiatry, telemedicine and remote mental health services. Major trends in the forecast period include regulatory changes, market competition, generic market growth, focus on side effect profiles, emerging markets. For further insights on the Antidepressants market, request a sample here

How is the Antidepressants market segmented?

The antidepressants market covered in this report is segmented –
1) By Product: Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhibitor (MAOI)
2) By Drug Class: Monoamine Oxidase Inhibitors, Serotonin Antagonist And Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants
3) By Depressive Disorder: Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder Subsegments:
1) By Selective Serotonin Reuptake Inhibitor (SSRI): Fluoxetine, Sertraline, Escitalopram, Paroxetine, Citalopram
2) By Serotonin-norepinephrine Reuptake Inhibitor (SNRI): Venlafaxine, Duloxetine, Desvenlafaxine
3) By Tricyclic Antidepressant (TCA): Amitriptyline, Nortriptyline, Imipramine, Doxepin
4) By Monoamine Oxidase Inhibitor (MAOI): Phenelzine, Tranylcypromine, Isocarboxazid For further insights on the Antidepressants market,
request a sample here

Which region has the largest share of the Antidepressants market? What are the other regions covered in the report?

North America was the largest region in the antidepressants market in 2024. Middle East is expected to be the largest growing region in the global antidepressants market during the forecast period. The regions covered in the antidepressants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Antidepressants market, request a sample here.

Who are the major players in the Antidepressants market?

Major companies operating in the antidepressants market include Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol Myers Squibb Company, Fresenius Kabi AG, Abbott Laboratories, AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd., Eli Lilly and Company, Boehringer Ingelheim GmbH, H. Lundbeck AS, Teva Pharmaceutical Industries Ltd., Akeda Pharmaceutical Co., Otsuka Pharmaceutical Co., Mylan N.V, Sun Pharmaceuticals Pvt. Ltd., Servier Laboratories, Sumitomo Dainippon Pharma Co., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Allergan plc, Alkermes plc, Egis Pharmaceuticals plc, Forest Laboratories Inc. . For further insights on the Antidepressants market, request a sample here.

What are the key trends in the Antidepressants market?

Major trends in the Antidepressants market include Ketamine Treatment Reshaping The Antidepressant Market. For further insights on the Antidepressants market, request a sample here.

What are the major opportunities in the Antidepressants market? What are the strategies for the Antidepressants market?

For detailed insights on the major opportunities and strategies in the Antidepressants market, request a sample here.

How does the Antidepressants market relate to the overall economy and other similar markets?

For detailed insights on Antidepressants's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Antidepressants industry?

For detailed insights on the mergers and acquisitions in the Antidepressants industry, request a sample here.

What are the key dynamics influencing the Antidepressants market growth? SWOT analysis of the Antidepressants market.

For detailed insights on the key dynamics influencing the Antidepressants market growth and SWOT analysis of the Antidepressants industry, request a sample here.